Skip to main content

. 1982 Mar;45(3):466–468. doi: 10.1038/bjc.1982.75

A comparison of the response of human lung carcinoma xenografts to vindesine and vincristine.

B D Evans, I E Smith, A J Shorthouse, J L Millar

PMCID: PMC2010925 PMID: 6280742

466

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Cobb L. M., Mitchley B. C. Development of a method for assessing the antitumor activity of chemotherapeutic agents using human tumor xenografts. Cancer Chemother Rep. 1974 Sep-Oct;58(5 Pt 1):645–651. [PubMed] [Google Scholar]
Kopper L., Steel G. G. The therapeutic response of three human tumor lines maintained in immune-suppressed mice. Cancer Res. 1975 Oct;35(10):2704–2713. [PubMed] [Google Scholar]
Mattson K., Holsti L. R., Salmo M., Saastamoinen M., Ahlstedt S., Holsti P. Vindesine in the treatment of small cell and non-small cell bronchogenic carcinoma: preliminary results. Cancer Treat Rev. 1980 Sep;7 (Suppl 1):65–70. doi: 10.1016/s0305-7372(80)80010-7. [DOI] [PubMed] [Google Scholar]
Shorthouse A. J., Smyth J. F., Steel G. G., Ellison M., Mills J., Peckham M. J. The human tumour xenograft--a valid model in experimental chemotherapy? Br J Surg. 1980 Oct;67(10):715–722. doi: 10.1002/bjs.1800671011. [DOI] [PubMed] [Google Scholar]
Steel G. G., Courtenay V. D., Rostom A. Y. Improved immune-suppression techniques for the exongrafting of human tumours. Br J Cancer. 1978 Feb;37(2):224–230. doi: 10.1038/bjc.1978.30. [DOI] [PMC free article] [PubMed] [Google Scholar]

ACTIONS

RESOURCES